Venlafaxine XR Adco 37.5 mg. 75 mg. 150 mg. 225 mg XR capsules
PDF Leaflet Revision Date: 30 November 2021
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of depression and anxiety disorders.
Dosage (summary)
Starting dose 75 mg once daily, may increase to 150 mg or 225 mg as needed.
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- MAOIs
- SSRIs
- SNRIs
- Triptans
Contraindications
- Hypersensitivity to venlafaxine
- Concomitant MAOIs
- Children under 18 years
Common side effects
- Nausea
- Dry mouth
- Headache
- Sweating
Counselling Points
- Take with food
- Do not crush or chew capsules
- Taper off gradually
Serious warnings
- Risk of suicidal thoughts
- Serotonin syndrome
- Increased blood pressure
Important Disclaimer
The Venlafaxine XR Adco 37.5 mg. 75 mg. 150 mg. 225 mg XR capsules professional information leaflet below is the property of Adcock Ingram and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
